Literature DB >> 11037337

False positives and false negatives in genome scans.

D C Rao1, C Gu.   

Abstract

It is emphasized that two types of errors are made in the testing of a hypothesis, false positive (type I) and false negative (type II). Genome-wide scans involving many markers give rise to the problem of multiple testing, which results in an increased number of false positives, thus necessitating a correction in the nominal significance level. While the literature has concentrated reasonably heavily on controlling false positives in genomic scans, the need to control false negatives has been largely neglected. This chapter highlights this need and attempts to strike a balance between the two error types. The need to develop alternative methods for discriminating between false positives and true positives is also stressed.

Mesh:

Year:  2001        PMID: 11037337     DOI: 10.1016/s0065-2660(01)42038-4

Source DB:  PubMed          Journal:  Adv Genet        ISSN: 0065-2660            Impact factor:   1.944


  22 in total

Review 1.  Searching for the mountains of the moon: genome scans for atherosclerosis.

Authors:  Michael A Province
Journal:  Curr Atheroscler Rep       Date:  2002-05       Impact factor: 5.113

2.  Considerations on study designs using the extreme sibpairs methods under multilocus oligogenic models.

Authors:  Chi Gu; D C Rao
Journal:  Genetics       Date:  2002-04       Impact factor: 4.562

3.  Genome-wide linkage analysis of pulse pressure in American Indians: the Strong Heart Study.

Authors:  Nora Franceschini; Jean W MacCluer; Kathreen M Rose; Sue Rutherford; Shelley A Cole; Sandy Laston; Harald H H Göring; Vincent P Diego; Mary J Roman; Elisa T Lee; Lyle G Best; Barbara V Howard; Richard R Fabsitz; Kari E North
Journal:  Am J Hypertens       Date:  2008-01-10       Impact factor: 2.689

4.  High throughput SNP and expression analyses of candidate genes for non-syndromic oral clefts.

Authors:  J W Park; J Cai; I McIntosh; E W Jabs; M D Fallin; R Ingersoll; J B Hetmanski; M Vekemans; T Attie-Bitach; M Lovett; A F Scott; T H Beaty
Journal:  J Med Genet       Date:  2006-01-13       Impact factor: 6.318

5.  Univariate and bivariate linkage analysis identifies pleiotropic loci underlying lipid levels and type 2 diabetes risk.

Authors:  Sandra J Hasstedt; Craig L Hanis; Steven C Elbein
Journal:  Ann Hum Genet       Date:  2010-07       Impact factor: 1.670

6.  Linkage analysis of glomerular filtration rate in American Indians.

Authors:  Amy K Mottl; Suma Vupputuri; Shelley A Cole; Laura Almasy; Harald H H Göring; Vincent P Diego; Sandra Laston; Nora Franceschini; Nawar M Shara; Elisa T Lee; Lyle G Best; Richard R Fabsitz; Jean W MacCluer; Jason G Umans; Kari E North
Journal:  Kidney Int       Date:  2008-08-13       Impact factor: 10.612

7.  Genome-wide linkage scan for plasma high density lipoprotein cholesterol, apolipoprotein A-1 and triglyceride variation among American Indian populations: the Strong Heart Family Study.

Authors:  X Li; K L Monda; H H H Göring; K Haack; S A Cole; V P Diego; L Almasy; S Laston; B V Howard; N M Shara; E T Lee; L G Best; R R Fabsitz; J W MacCluer; Kari E North
Journal:  J Med Genet       Date:  2009-05-07       Impact factor: 6.318

8.  Genome-wide discovery of loci influencing chemotherapy cytotoxicity.

Authors:  James W Watters; Aldi Kraja; Melissa A Meucci; Michael A Province; Howard L McLeod
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-28       Impact factor: 11.205

9.  Evidence of linkage in a Hispanic cohort with a Class III dentofacial phenotype.

Authors:  S Frazier-Bowers; R Rincon-Rodriguez; J Zhou; K Alexander; E Lange
Journal:  J Dent Res       Date:  2009-01       Impact factor: 6.116

10.  Candidate gene polymorphisms for diabetes mellitus, cardiovascular disease and cancer are associated with longevity in Koreans.

Authors:  Ji Wan Park; Yong Ick Ji; Yoon Ho Choi; Mi Yeon Kang; Eunhyun Jung; Se Young Cho; Hee-Youn Cho; Byung Kyu Kang; Yoo Sook Joung; Duk-Hwan Kim; Sang Chul Park; Joobae Park
Journal:  Exp Mol Med       Date:  2009-11-30       Impact factor: 8.718

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.